Statistics for 2seventy bio, (id:8041 TSVT)

Valuation metrics

Market cap

212.69M

Enterprise value

269.93M

Trailing P/E (ttm)

-0.82

Forward P/E

-9.60

PEG ratio

-9.60

Price/Sales (ttm)

4.82

Price/Book (mrq)

0.82

Enterprise Value/Revenue

6.12

Enterprise Value/EBITDA

-1.53

Overview

Shares outstanding

51.50M

Float

50.00M

Shares short

5.42M

% Held by insiders

0.04%

% Held by institutions

0.96%

Average volume (10 days)

402.27K

Average volume (90 days)

Price summary

52-Week low

1.68

52-Week high

6.40

52-Week change

49.58%

Beta

1.79

50-Day moving average

4.75

200-Day moving average

4.70

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

83.15%

Operating margin

-227.01%

Operational effectiveness

Return on assets

-19.02%

Return on equity

-51.89%

Income statement

Revenue (ttm)

0.85

Revenue per share (ttm)

0.85

Quarterly revenue growth (yoy)

Gross profit (ttm)

83.47M

EBITDA

-176,560,000.00

Net income to common (ttm)

-156,254,000.00

Diluted EPS (ttm)

-3.06

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

201.87M

Total cash per share (mrq)

3.92

Total debt (mrq)

251.40M

Total Debt/Equity (mrq)

107.07

Current ratio (mrq)

476.40%

Book value per share (mrq)

5.04

Cash flow

Cash flow statement

-150,126,000.00

Levered free cash flow (LFCF)

-84,921,376.00